Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scimed Life Systems is a prominent medical device company specializing in interventional cardiology and vascular technology. Founded in 1971, the company became a global leader in the development of coronary angioplasty catheters, stents, and other minimally invasive surgical tools. In 1995, Scimed was acquired by Boston Scientific in a transformative merger that established Boston Scientific as a dominant force in the cardiovascular market. The entity continues to operate as a key subsidiary, Boston Scientific Scimed, Inc., holding numerous patents and driving innovation in stent delivery systems and vascular intervention technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scimed Life Systems.